Vaccine News and Research

Latest Vaccine News and Research

A model of vaccine-derived herd immunity against COVID-19 in heterogeneous populations

A recent theoretical paper, currently available on the medRxiv preprint server, unveils a novel vaccination model that shows how a herd immunity threshold (HIT) value which considers heterogeneity is substantially lower in comparison with a HIT value of assuming a homogeneous population – with many implications for further vaccination planning.

2 Mar 2021

Survey reveals impact of Pfizer-BioNTech vaccination in the UK

Researchers at Imperial College London in the UK have reported on round five of the REal-time Assessment of Community Transmission-2 (REACT-2) program – a cross-sectional community survey measuring the prevalence of antibodies against the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among adults in England.

2 Mar 2021

New computer algorithm offers a path toward pan-influenza and coronavirus vaccine

A novel computer algorithm that could create a broadly reactive influenza vaccine for swine flu also offers a path toward a pan-influenza vaccine and possibly a pan-coronavirus vaccine as well, according to a new paper published in Nature Communications.

2 Mar 2021

New nanoparticle-delivered COVID-19 vaccine candidate shows efficacy in ferret model

Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models.

2 Mar 2021

Readers and tweeters dispense timely advice for difficult times

Your body’s immune system has produced antibodies that will kill a few thousand kinds of germs and virus. Since you are alive, the chances are quite high you will survive its producing another. Here is how the system works.

2 Mar 2021

‘An Arm and a Leg’: Revisiting insulin: How the medicine got so expensive

We're re-releasing a story we first reported in 2019, about how insulin got to be so expensive. And this 2021 update includes a check-in with people working to make the potentially lifesaving medicine more available.

2 Mar 2021

Beijing’s SARS lockdown taught my children resilience. Your Covid kids will likely be fine.

Many parents are filled with angst as they prepare for their children to exit a year of pandemic isolation: Will it be OK to send them to school, per the recent recommendation from the Centers for Disease Control and Prevention? Will school feel like school if students are masked and can't trade snacks? Will children's development be impaired by nearly a year of seeing few friends?

2 Mar 2021

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine

Caused by SARS-CoV-2, the coronavirus disease 2019 (COVID-19) pandemic continues to spread across the globe.

From Evonik 2 Mar 2021

Ethnic minorities have less access to COVID-19 vaccines, finds study

A new study discusses the results of a survey including well over 1.3 million participants in the UK and the USA. During the initial part of the vaccination campaign – that is, the phase including February 1, 2021 – the researchers found significantly more hesitancy towards the vaccine among Black, Asian, and Hispanic communities, as well as greater difficulty in accessing vaccines among them.

2 Mar 2021

Sorting out how politics, policies figure in flap over New York nursing home Covid death rates

The plaudits have faded for New York Gov. Andrew Cuomo. Once hailed as a paragon of pandemic governing, he's since come under scorching criticism for undercounting the state's covid deaths among nursing home residents by as much as half.

2 Mar 2021

Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies

A thought-provoking new study server discusses the factors that determine the successful use of available vaccines to mitigate incidence and mortality rates for COVID-19.

2 Mar 2021

Moderna vaccine reduces viral spread by at least 60 percent, finds study

An interesting new study by researchers at Harvard T.H. Chan School of Public Health in the U.S. suggests that the currently used Moderna vaccine reduces viral shedding by about 60%.

2 Mar 2021

Experimental therapy delays viral rebound in SHIV-infected macaques

A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected macaques after antiretroviral therapy (ART) interruption.

2 Mar 2021

Study: Public attitude toward COVID-19 and its treatments is more “infectious” than disease itself

Public attitude toward COVID-19 and its treatments is more "infectious" than the disease itself, according to a new Northwestern Medicine study using Artificial Intelligence (AI) to analyze tweets about the virus.

2 Mar 2021

Study: Inaccurate information is a barrier to good health care, education

While many people believe misinformation on Facebook and Twitter from time to time, people with lower education or health literacy levels, a tendency to use alternative medicine, or distrust of the health care system are more likely to believe inaccurate medical postings than others, according to research published by the American Psychological Association.

1 Mar 2021

Scientists establish infection models for SARS-CoV-2 UK & South African variants

New research suggests Syrian golden hamsters could be a potentially useful preclinical model for testing vaccine immunity against the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.17 and B.1.351 variant.

1 Mar 2021

Enduring antibody response observed after natural immunity and first Pfizer SARS-CoV-2 vaccine shot

Immunity gained after natural infection from the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is boosted when people take the first Pfizer-BioNTech vaccine, according to a new study led by Iain C. Chapple from the University of Birmingham.

1 Mar 2021

Tier 3 interventions needed to contain SARS-CoV-2 transmission, especially with emergence of variants

Studies have shown that non-pharmaceutical interventions (NPIs) such as social distancing and partial lockdowns effectively contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. However, because of these measures' huge economic and social cost, the UK introduced a less socially disruptive tier system. This system was aimed at providing a consistent set of control measures with geographic flexibility.

1 Mar 2021

New vaccination strategy could eliminate the bacteria that cause UTIs

Anyone who has ever developed a urinary tract infection (UTI) knows that it can be painful, pesky and persistent. UTIs have a high recurrence rate and primarily afflict women -- as many as 50% of women will experience at least one UTI during their lifetime.

1 Mar 2021

High level of COVID-19 vaccine hesitancy found among Black Americans

Black Americans have a high level of vaccine hesitancy and mistrust of COVID-19 vaccines, including among Black health care workers, according to a new RAND Corporation survey.

1 Mar 2021

Vaccine News and Research

Latest Vaccine News and Research

A model of vaccine-derived herd immunity against COVID-19 in heterogeneous populations

Survey reveals impact of Pfizer-BioNTech vaccination in the UK

New computer algorithm offers a path toward pan-influenza and coronavirus vaccine

New nanoparticle-delivered COVID-19 vaccine candidate shows efficacy in ferret model

Readers and tweeters dispense timely advice for difficult times

‘An Arm and a Leg’: Revisiting insulin: How the medicine got so expensive

Beijing’s SARS lockdown taught my children resilience. Your Covid kids will likely be fine.

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine

Ethnic minorities have less access to COVID-19 vaccines, finds study

Sorting out how politics, policies figure in flap over New York nursing home Covid death rates

Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies

Moderna vaccine reduces viral spread by at least 60 percent, finds study

Experimental therapy delays viral rebound in SHIV-infected macaques

Study: Public attitude toward COVID-19 and its treatments is more “infectious” than disease itself

Study: Inaccurate information is a barrier to good health care, education

Scientists establish infection models for SARS-CoV-2 UK & South African variants

Enduring antibody response observed after natural immunity and first Pfizer SARS-CoV-2 vaccine shot

Tier 3 interventions needed to contain SARS-CoV-2 transmission, especially with emergence of variants

New vaccination strategy could eliminate the bacteria that cause UTIs

High level of COVID-19 vaccine hesitancy found among Black Americans

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in